152 related articles for article (PubMed ID: 21637024)
1. Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition.
Jones SE; Whitehead K; Saulnier D; Thomas CM; Versalovic J; Britton RA
Gut Microbes; 2011; 2(2):69-79. PubMed ID: 21637024
[TBL] [Abstract][Full Text] [Related]
2. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling.
Thomas CM; Hong T; van Pijkeren JP; Hemarajata P; Trinh DV; Hu W; Britton RA; Kalkum M; Versalovic J
PLoS One; 2012; 7(2):e31951. PubMed ID: 22384111
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun.
Lin YP; Thibodeaux CH; Peña JA; Ferry GD; Versalovic J
Inflamm Bowel Dis; 2008 Aug; 14(8):1068-83. PubMed ID: 18425802
[TBL] [Abstract][Full Text] [Related]
6. FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.
Thomas CM; Saulnier DM; Spinler JK; Hemarajata P; Gao C; Jones SE; Grimm A; Balderas MA; Burstein MD; Morra C; Roeth D; Kalkum M; Versalovic J
Microbiologyopen; 2016 Oct; 5(5):802-818. PubMed ID: 27353144
[TBL] [Abstract][Full Text] [Related]
7. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors.
Jones SE; Versalovic J
BMC Microbiol; 2009 Feb; 9():35. PubMed ID: 19210794
[TBL] [Abstract][Full Text] [Related]
8. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
[TBL] [Abstract][Full Text] [Related]
9. Characterizing how probiotic
Quach D; Parameswaran N; McCabe L; Britton RA
Bone Rep; 2019 Dec; 11():100227. PubMed ID: 31763377
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
Wang Z; Wang L; Chen Z; Ma X; Yang X; Zhang J; Jiang Z
J Microbiol Biotechnol; 2016 Jun; 26(6):1018-25. PubMed ID: 26907754
[TBL] [Abstract][Full Text] [Related]
11. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of the cyclopropane fatty acid synthase of Brucella abortus.
Palacios-Chaves L; Zúñiga-Ripa A; Gutiérrez A; Gil-Ramírez Y; Conde-Álvarez R; Moriyón I; Iriarte M
Microbiology (Reading); 2012 Apr; 158(Pt 4):1037-1044. PubMed ID: 22262102
[TBL] [Abstract][Full Text] [Related]
13. Human phagocytic cell response to histamine derived from potential probiotic strains of Lactobacillus reuteri.
Greifová G; Body P; Greif G; Greifová M; Dubničková M
Immunobiology; 2018 Nov; 223(11):618-626. PubMed ID: 30037587
[TBL] [Abstract][Full Text] [Related]
14. Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation.
Röth D; Chiang AJ; Hu W; Gugiu GB; Morra CN; Versalovic J; Kalkum M
FASEB J; 2019 Mar; 33(3):3536-3548. PubMed ID: 30452879
[TBL] [Abstract][Full Text] [Related]
15. An active site mutant of Escherichia coli cyclopropane fatty acid synthase forms new non-natural fatty acids providing insights on the mechanism of the enzymatic reaction.
E G; Drujon T; Correia I; Ploux O; Guianvarc'h D
Biochimie; 2013 Dec; 95(12):2336-44. PubMed ID: 23954860
[TBL] [Abstract][Full Text] [Related]
16. Biodetoxification of fungal mycotoxins zearalenone by engineered probiotic bacterium Lactobacillus reuteri with surface-displayed lactonohydrolase.
Liu F; Malaphan W; Xing F; Yu B
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8813-8824. PubMed ID: 31628520
[TBL] [Abstract][Full Text] [Related]
17. From prediction to function using evolutionary genomics: human-specific ecotypes of Lactobacillus reuteri have diverse probiotic functions.
Spinler JK; Sontakke A; Hollister EB; Venable SF; Oh PL; Balderas MA; Saulnier DM; Mistretta TA; Devaraj S; Walter J; Versalovic J; Highlander SK
Genome Biol Evol; 2014 Jun; 6(7):1772-89. PubMed ID: 24951561
[TBL] [Abstract][Full Text] [Related]
18. Cloning and heterologous expression of Lactobacillus reuteri uroporphyrinogen III synthase/methyltransferase gene (cobA/hemD): preliminary characterization.
Vannini V; Rodríguez A; Vera JL; de Valdéz GF; Taranto MP; Sesma F
Biotechnol Lett; 2011 Aug; 33(8):1625-32. PubMed ID: 21484341
[TBL] [Abstract][Full Text] [Related]
19. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features.
Saulnier DM; Santos F; Roos S; Mistretta TA; Spinler JK; Molenaar D; Teusink B; Versalovic J
PLoS One; 2011 Apr; 6(4):e18783. PubMed ID: 21559529
[TBL] [Abstract][Full Text] [Related]
20. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri.
Luo H; Li P; Wang H; Roos S; Ji B; Nielsen J
BMC Biotechnol; 2021 Jul; 21(1):46. PubMed ID: 34330235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
